Stock listing
NASDAQ:SCNX Scienture Holdings, Inc. Stock
Home listing (NASDAQ) of Scienture Holdings, Inc.
Follow Scienture Holdings, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SCNX
$3.13 USD +0.02 (+0.8%)
Close on Nov 6, 2026
- Day range
- $3.04 – $3.25 USDNov 6, 2026
- Volume
- 7,595 sharesNov 6, 2026
- Market cap
- $5.13M USDAt the close on Nov 6, 2026 · price × 1.64M shares outstanding
- 52-week range
- $2.64 – $19.48 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $132,357 USDMedian day 1,600 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SCNX · Home | $3.125 USD | +0.025 (+0.8%) | 7,595 | $3.174 | $3.25 | $3.04 | $3.10 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:SCNX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.125 | +0.025 | +0.8% | $3.174 | $3.25 | $3.04 | 7,595 | |
| $3.10 | -0.32 | -9.4% | $3.32 | $3.41 | $3.06 | 32,585 | |
| $3.42 | -0.03 | -0.9% | $3.29 | $3.47 | $3.29 | 14,050 | |
| $3.45 | +0.22 | +6.8% | $3.20 | $3.45 | $3.13 | 12,678 | |
| $3.23 | +0.01 | +0.3% | $3.13 | $3.245 | $3.13 | 6,133 | |
| $3.22 | -0.27 | -7.7% | $3.42 | $3.42 | $3.18 | 11,378 | |
| $3.49 | +0.09 | +2.6% | $3.31 | $3.67 | $3.31 | 58,342 | |
| $3.40 | +0.17 | +5.3% | $3.10 | $3.40 | $3.10 | 41,236 | |
| $3.23 | +0.30 | +10.2% | $2.965 | $3.23 | $2.82 | 37,149 | |
| $2.93 | +0.05 | +1.7% | $3.04 | $3.04 | $2.915 | 16,355 | |
| $2.88 | +0.11 | +4.0% | $2.73 | $2.89 | $2.64 | 69,869 | |
| $2.77 | -0.135 | -4.6% | $2.84 | $2.84 | $2.70 | 31,023 | |
| $2.905 | -0.145 | -4.8% | $3.04 | $3.095 | $2.85 | 24,598 | |
| $3.05 | +0.13 | +4.5% | $2.988 | $3.051 | $2.921 | 22,294 | |
| $2.92 | -0.44 | -13.1% | $3.39 | $3.39 | $2.81 | 75,406 | |
| $3.36 | -0.02 | -0.6% | $3.38 | $3.42 | $3.25 | 24,100 | |
| $3.38 | +0.03 | +0.9% | $3.68 | $3.68 | $3.21 | 52,600 | |
| $3.35 | +0.11 | +3.4% | $3.33 | $3.52 | $3.27 | 38,600 | |
| $3.24 | -0.67 | -17.1% | $3.93 | $3.93 | $3.24 | 464,400 | |
| $3.91 | +0.15 | +4.0% | $3.79 | $3.91 | $3.581 | 37,600 | |
| $3.76 | -0.10 | -2.6% | $3.79 | $3.84 | $3.651 | 32,000 | |
| $3.86 | -0.27 | -6.5% | $4.26 | $4.26 | $3.76 | 70,700 | |
| $4.13 | +0.37 | +9.8% | $3.85 | $4.20 | $3.649 | 106,800 | |
| $3.76 | +0.05 | +1.3% | $3.23 | $4.14 | $3.23 | 214,800 | |
| $3.71 | -0.265 | -6.7% | $3.89 | $4.25 | $3.56 | 245,200 | |
| $3.975 | -0.45 | -10.2% | $5.275 | $5.35 | $3.35 | 261,418 | |
| $4.425 | -2.075 | -31.9% | $5.15 | $5.15 | $4.40 | 3,094 | |
| $6.50 | -0.175 | -2.6% | $6.675 | $6.775 | $6.30 | 1,013 | |
| $6.675 | -0.075 | -1.1% | $6.60 | $6.85 | $6.50 | 604 | |
| $6.75 | -0.175 | -2.5% | $6.775 | $6.90 | $6.50 | 635 | |
| $6.925 | -0.25 | -3.5% | $7.00 | $7.25 | $6.75 | 662 | |
| $7.175 | -0.075 | -1.0% | $7.025 | $7.25 | $6.975 | 492 | |
| $7.25 | +0.125 | +1.8% | $7.05 | $7.275 | $6.95 | 1,768 | |
| $7.125 | -0.50 | -6.6% | $8.05 | $8.725 | $7.025 | 26,085 | |
| $7.625 | -0.225 | -2.9% | $7.80 | $8.00 | $7.475 | 686 | |
| $7.85 | +0.025 | +0.3% | $7.75 | $8.05 | $7.75 | 471 | |
| $7.825 | -0.45 | -5.4% | $8.025 | $8.125 | $7.775 | 546 | |
| $8.275 | -0.025 | -0.3% | $8.25 | $8.275 | $8.05 | 391 | |
| $8.30 | -0.175 | -2.1% | $8.30 | $8.60 | $8.30 | 225 | |
| $8.475 | -0.225 | -2.6% | $8.75 | $8.825 | $8.375 | 436 | |
| $8.70 | -0.25 | -2.8% | $8.95 | $9.225 | $8.50 | 384 | |
| $8.95 | -0.225 | -2.5% | $8.925 | $9.25 | $8.675 | 572 | |
| $9.175 | +0.075 | +0.8% | $8.50 | $9.625 | $8.425 | 14,250 | |
| $9.10 | -0.225 | -2.4% | $9.425 | $9.425 | $8.90 | 357 | |
| $9.325 | +0.075 | +0.8% | $9.45 | $9.45 | $9.025 | 226 | |
| $9.25 | 0.00 | 0.0% | $9.30 | $9.525 | $9.00 | 477 | |
| $9.25 | +0.075 | +0.8% | $9.35 | $9.575 | $9.025 | 193 | |
| $9.175 | -0.55 | -5.7% | $9.75 | $9.75 | $8.825 | 606 | |
| $9.725 | -0.125 | -1.3% | $9.85 | $9.85 | $9.425 | 245 | |
| $9.85 | +0.35 | +3.7% | $9.875 | $10.00 | $9.525 | 437 | |
| $9.50 | -0.10 | -1.0% | $9.50 | $9.875 | $9.125 | 422 | |
| $9.60 | -0.725 | -7.0% | $10.23 | $10.25 | $9.60 | 606 | |
| $10.33 | -0.50 | -4.6% | $10.63 | $11.25 | $10.25 | 521 | |
| $10.83 | -0.425 | -3.8% | $11.00 | $11.50 | $10.52 | 569 | |
| $11.25 | -0.55 | -4.7% | $12.00 | $12.00 | $11.05 | 340 | |
| $11.80 | -0.05 | -0.4% | $11.50 | $12.02 | $11.50 | 582 | |
| $11.85 | +0.425 | +3.7% | $11.50 | $12.00 | $10.78 | 1,088 | |
| $11.43 | -0.30 | -2.6% | $11.43 | $12.00 | $11.03 | 893 | |
| $11.73 | +0.25 | +2.2% | $11.25 | $11.92 | $11.00 | 1,431 | |
| $11.48 | -0.15 | -1.3% | $11.25 | $11.68 | $10.25 | 47,515 | |
| $11.63 | +0.375 | +3.3% | $10.50 | $11.73 | $10.27 | 1,879 | |
| $11.25 | +1.025 | +10.0% | $10.50 | $11.63 | $9.10 | 52,901 | |
| $10.23 | -0.15 | -1.4% | $10.50 | $10.50 | $10.00 | 338 | |
| $10.38 | +0.875 | +9.2% | $9.45 | $10.50 | $9.45 | 970 | |
| $9.50 | +0.175 | +1.9% | $9.25 | $9.70 | $9.20 | 173 | |
| $9.325 | -0.40 | -4.1% | $9.35 | $9.725 | $9.225 | 416 |
- Ticker
- NASDAQ:SCNX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
Latest deck · Sep 14, 2026
Investor Presentation (September 2026)
Investor deck · 17 slides
Calls
Replays
TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Call
Mon, May 15, 2023 · 6:00 PM ET
Watch TranscriptTRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Call
Mon, Mar 27, 2023 · 5:30 PM ET
Watch TranscriptTRxADE HEALTH, Inc. (MEDS) Q3 2022 Earnings Call
Mon, Nov 07, 2022 · 5:00 PM ET
Watch Transcript
Latest news
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
Oct 22, 2026
Closed $2.77 (-4.6%) on Oct 22, 2026
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Oct 13, 2026
Closed $3.24 (-17.1%) on Oct 13, 2026
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
Oct 2, 2026
Closed $3.98 (-10.2%) on Oct 2, 2026
Scienture Holdings, Inc. Announces Reverse Stock Split
Sep 30, 2026
Closed $4.43 (-31.9%) on Oct 1, 2026
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Sep 22, 2026
Closed $7.12 (-6.6%) on Sep 22, 2026
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
Sep 9, 2026
Closed $9.17 (+0.8%) on Sep 9, 2026
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
Aug 12, 2026
Closed $11.25 (+10.0%) on Aug 12, 2026
Securonix Takes on Data Costs, Detection Gaps, and AI Agent Risk at Black Hat USA 2026
Aug 3, 2026
Closed $9.68 (+1.6%) on Aug 3, 2026
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers
Jul 9, 2026
Closed $8.33 (+0.6%) on Jul 9, 2026
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
Jun 18, 2026
Closed $9.55 (-1.5%) on Jun 18, 2026
Financings
Registered direct offering of shares of common stock
Aug 14, 2025
Announced: about US$3.9M · US$1.2 a share · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Private placement of shares of common stock
Jul 24, 2025
Announced: up to US$3M
Use of proceeds: Supporting upcoming commercial launches of its products and pipeline program development
Shares of common stock under equity line of credit
Jun 17, 2025
Cancelled: raise
Buyers: Arena Business Solutions (up to $50 million of shares of common stock over 36 months)
Use of proceeds: To support pre-launch and commercial launch activities for Arbli (losartan potassium) Oral Suspension
Announced Nov 26, 2024 · Tranche closed Mar 19, 2025 · Cancelled Jun 17, 2025
Private placement of 10% secured convertible debentures
Nov 26, 2024
Tranche closed: US$3.33M raised · Dawson James Securities, Inc.
Dealers: Dawson James Securities, Inc. (lead)
Buyers: Arena Investors, LP (certain affiliates of Arena to buy debentures of up to $12,222,222 principal amount in three tranches)
Use of proceeds: Working capital and other general corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 17 slides · Sep 14, 2026
Investor Presentation (May 2026)
Investor deck · 17 slides · May 5, 2026
Investor Presentation (November 2025)
Investor deck · 22 slides · Nov 18, 2025
Investor Presentation (January 2025)
Investor deck · 27 slides · Jan 8, 2025
Scienture Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 26 in the last 12 months · 113 in all · newest Oct 22, 2026 · oldest 2021
- Calls
- 11 calls with a replay · 11 with a transcript · latest May 15, 2023
- Decks
- 19 decks · latest Sep 14, 2026
Where Scienture Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SCNX · Home listing · This page | NASDAQ | United States | USD |
| Tradegate:4E4 | Tradegate | Germany | EUR |
| BOATS:SCNX | BOATS | United States | USD |
| Frankfurt:4E4 | Frankfurt | Germany | EUR |
| Hamburg:4E4 | Hamburg | Germany | EUR |
Log in to ask 6ix AI your own questions about Scienture Holdings, Inc.